| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
PT Prodia Widyahusada Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp3,010.00 |
| 52 Week High | Rp6,800.00 |
| 52 Week Low | Rp3,000.00 |
| Beta | 0.095 |
| 1 Month Change | -8.23% |
| 3 Month Change | -34.57% |
| 1 Year Change | -47.19% |
| 3 Year Change | -27.64% |
| 5 Year Change | -14.49% |
| Change since IPO | -54.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| PRDA | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | -3.2% | -0.5% | -3.1% |
| 1Y | -47.2% | 7.9% | 3.7% |
Return vs Industry: PRDA underperformed the ID Healthcare industry which returned 7.9% over the past year.
Return vs Market: PRDA underperformed the ID Market which returned 3.7% over the past year.
Price Volatility
| PRDA volatility | |
|---|---|
| PRDA Average Weekly Movement | 4.0% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in ID Market | 12.7% |
| 10% least volatile stocks in ID Market | 2.5% |
Stable Share Price: PRDA's share price has been volatile over the past 3 months.
Volatility Over Time: PRDA's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1973 | 2,956 | Dewi Muliaty | prodia.co.id/id |
PT Prodia Widyahusada Tbk provides clinical laboratory services primarily in Indonesia. The company offers laboratory, genomic, non-laboratory, and panel test services. It also operates Prodia health care and specialty clinics; and offers vaccination services.
PT Prodia Widyahusada Tbk Fundamentals Summary
| PRDA fundamental statistics | |
|---|---|
| Market cap | Rp2.82t |
| Earnings (TTM) | Rp227.50b |
| Revenue (TTM) | Rp2.19t |
12.4x
P/E Ratio1.3x
P/S RatioIs PRDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRDA income statement (TTM) | |
|---|---|
| Revenue | Rp2.19t |
| Cost of Revenue | Rp948.54b |
| Gross Profit | Rp1.24t |
| Other Expenses | Rp1.02t |
| Earnings | Rp227.50b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 242.66 |
| Gross Margin | 56.72% |
| Net Profit Margin | 10.38% |
| Debt/Equity Ratio | 0.1% |
How did PRDA perform over the long term?
See historical performance and comparison